US2007231830A1PendingUtilityA1
Method for identifying inhibitors of G protein coupled receptor signaling
Est. expiryMar 14, 2021(expired)· nominal 20-yr term from priority
A61P 9/10A61P 9/04A61P 37/08A61P 43/00A61P 9/12A61P 31/12A61P 25/20A61P 31/10A61P 25/16A61P 35/00A61P 25/22A61P 25/08A61P 25/24A61P 25/18A61P 31/04A61P 25/28A61P 29/00A61P 25/34A61P 3/04A61P 33/00A61P 31/18A61P 19/10C07K 1/047A61P 13/08A61P 15/08G01N 2333/726A61P 13/02G01N 2500/02A61P 11/06A61P 1/04G01N 33/566
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to methods for identifying peptides and other compounds which block G protein coupled receptor mediated signaling with high affinity and specificity. Assays developed in conjunction with these methods also are disclosed.
Claims
exact text as granted — not AI-modified1 . A method of identifying a G protein coupled receptor (GPCR) signaling inhibitor, which comprises:
(a) providing a first library comprising peptide members, wherein the primary sequences of said peptide members are based on the primary sequence of the native G protein peptide that binds to said GPCR on the G protein binding domain of said GPCR; (b) screening said peptide first library members for binding to said G protein binding domain of said GPCR in competition with a native peptide that comprises said primary sequence of the native G protein of (a), to identify peptide first library members that bind to said GPCR G protein binding domain with higher affinity than that of said native peptide; (c) selecting a high-affinity peptide first library member identified in (b); (d) providing a second library of member compounds; (e) screening said second library member compounds for binding to said GPCR G protein binding domain, wherein said screening is a binding assay performed in the presence of the peptide selected in (c), to determine whether a second library member compound binds to said GPCR G protein binding domain with equal or higher affinity than that of said second competitive peptide.
2 . The method of claim 1 , wherein said screening of (b) or (e) is testing for binding to a GPCR molecule that comprises at least the intracellular fragment of said GPCR.
3 . The method of claim 1 , wherein said native G protein peptide is selected from the group consisting of a Gα subunit or carboxyl terminal fragment thereof.
4 . The method of claim 3 , wherein said native G protein peptide is a Gα subunit carboxyl terminal fragment from about 7 to about 70 amino acids long.
5 . The method of claim 3 , wherein said native G protein peptide is a Gα subunit carboxyl terminal fragment from about 9 to about 23 amino acids long.
6 . The method of claim 3 , wherein said native G protein peptide is a Gα subunit carboxyl terminal fragment from about 11 amino acids long.
7 . The method of claim 3 , wherein said G protein subunit is a Gβγ dimer.
8 . The method of claim 1 , wherein said first library peptide members provide signal to detect binding.
9 . The method of claim 1 , wherein said first library is a combinatorial peptide library.
10 . The method of claim 9 , wherein said combinatorial peptide library is a protein-peptide fusion protein library.
11 . The method of claim 10 , wherein said protein-peptide fusion protein library is a maltose binding protein-peptide fusion protein library.
12 . The method of claim 11 , wherein said peptide library is a peptide display library.
13 . The method of claim 1 , wherein said second library of member compounds is a small molecule library.
14 . A compound identified by a method of claim 1 .
15 . A method of selecting a G protein coupled receptor (GPCR) signaling inhibitor peptide, which comprises:
(a) providing a library comprising peptide members, wherein the primary sequences of said peptide members are based on the primary sequence of the native G protein peptide that binds to said GPCR on the G protein binding domain of said GPCR; (b) screening said peptide library members for binding to said G protein binding domain of said GPCR in competition with a native peptide that comprises said primary sequence of the native G protein of (a), to identify peptide first library members that bind to said GPCR G protein binding domain with higher affinity than that of said native peptide; (c) selecting a high-affinity peptide first library member identified in (b).
16 . The method of claim 15 , wherein said screening of (b) is testing for binding to a GPCR molecule that comprises at least the intracellular fragment of said GPCR.
17 . The method of claim 15 , wherein said native G protein peptide is selected from the group consisting of a Gα subunit or carboxyl terminal fragment thereof.
18 . The method of claim 17 , wherein said native G protein peptide is a Gα subunit carboxyl terminal fragment from about 7 to about 70 amino acids long.
19 . The method of claim 17 , wherein said native G protein peptide is a Gα subunit carboxyl terminal fragment from about 9 to about 23 amino acids long.
20 . The method of claim 17 , wherein said native G protein peptide is a Gα subunit carboxyl terminal fragment from about 11 amino acids long.
21 . The method of claim 17 , wherein said G protein subunit is a Gβγ dimer.
22 . The method of claim 15 , wherein said first library peptide members provide signal to detect binding.
23 . The method of claim 15 , wherein said first library is a combinatorial peptide library.
24 . The method of claim 23 , wherein said combinatorial peptide library is a protein-peptide fusion protein library.
25 . The method of claim 24 , wherein said protein-peptide fusion protein library is a maltose binding protein-peptide fusion protein library.
26 . The method of claim 25 , wherein said peptide library is a peptide display library.
27 . The method of claim 15 , wherein said second library of member compounds is a small molecule library.
28 . A compound identified by a method of claim 15 .
29 . A method of identifying a G protein coupled receptor (GPCR) signaling inhibitor, which comprises:
(a) providing a library of candidate compounds to screen for binding to said G protein coupled receptor; (b) providing a peptide that binds to said GPCR G protein binding domain with higher affinity than that of its native peptide; (c) screening said library of candidate compounds for binding to said GPCR G protein binding domain in the presence of said peptide of (b), to determine whether a candidate compound binds to said GPCR G protein binding domain with equal or higher affinity than that of said peptide of (b).
30 . The method of claim 29 , wherein said screening of (c) is testing for binding to a GPCR molecule that comprises at least the intracellular fragment of said GPCR.
31 . The method of claim 29 , wherein said library of candidate compounds is a small molecule library.
32 . A compound identified by a method of claim 29 .
33 . The method of claim 31 , wherein said library of candidate compounds is a focused library of candidate compounds based on the structure of the peptide of (b).
34 . The method of claim 31 , wherein said library of candidate compounds of step (a) is a combinatorial library.
35 . The method of claim 34 , wherein said combinatorial library is a diverse small molecule library.
36 . The method of claim 35 , wherein said diverse small molecule combinational library comprises drug-like molecules.
37 . The method of claim 35 , wherein said diverse small molecule combinational library is a focused small molecule library.
38 . The method of inhibiting G protein coupled receptor signaling in a cell having a G protein coupled receptor which comprises administering to said cell in vitro a compound identified according to a method of claim 1 .
39 . The method of inhibiting G protein coupled receptor signaling in a cell having a G protein coupled receptor which comprises administering to said cell in vitro a compound identified according to a method of claim 15 .
40 . The method of inhibiting G protein coupled receptor signaling in a cell having a G protein coupled receptor which comprises administering to said cell in vitro a compound identified according to a method of claim 29 .
41 . A compound identified by the method of claim 15 , which comprises a peptide selected from the group consisting of SEQ ID NOS: 2, 13, 15, 17, 19, 21, 23, 25, 27, 30, 32, 34, 36, 38, 40, 42 and 45-111.
42 . A compound selected from the group consisting of SEQ ID NOS: 2, 13, 15, 17, 19, 21, 23, 25, 27, 30, 32, 34, 36, 38, 40, 42 and 45-111.Join the waitlist — get patent alerts
Track US2007231830A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.